<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01488461</url>
  </required_header>
  <id_info>
    <org_study_id>NI 08034</org_study_id>
    <secondary_id>AOM 09178</secondary_id>
    <nct_id>NCT01488461</nct_id>
  </id_info>
  <brief_title>Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias</brief_title>
  <acronym>ATAXIC</acronym>
  <official_title>Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital ataxias (CA) are rare, non progressive diseases, characterized by psychomotor&#xD;
      retardation, hypotonia followed by ataxia. The presence of the &quot;molar tooth&quot; on MRI allowed&#xD;
      to define Joubert syndrome, a peculiar form of CA. Apart from this group, CA are mostly&#xD;
      associated with cerebellar atrophy or hypoplasia without molar tooth on MRI. CA are a&#xD;
      clinically as well as genetically heterogeneous group of diseases. Early-onset ataxias are&#xD;
      progressive but may be difficult to distinguish from CA in the first years of the disease. To&#xD;
      date, few genes responsible for CA have been identified: ABC7 (X-linked CA associated with&#xD;
      sideroblastic anemia), SLC9A6 (X-linked CA associated with severe mental retardation, autism&#xD;
      and epilepsy), GPR56 (CA associated with polymicrogyria), ATCAY (pure CA in Cayman isolate);&#xD;
      the involvement of the ATCAY and ABC7 genes has never been assessed in a large cohort of CA&#xD;
      patients.&#xD;
&#xD;
      Primary objective:&#xD;
&#xD;
      To assess the frequency of mutations of the ATCAY and ABC7 genes in patients affected with&#xD;
      non Joubert congenital or early-onset ataxia.&#xD;
&#xD;
      Secondary objective:&#xD;
&#xD;
      To identify new loci and/or genes responsible for CA To further describe the clinical&#xD;
      phenotype of the CA and to assess the frequency of the various clinical types (pure CA/CA&#xD;
      associated with spasticity/ syndromic CA, congenital/early-onset CA, sporadic/familial CA).&#xD;
&#xD;
      To describe the clinical phenotype of CA related to mutations in one of analysed genes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients will be examined by a geneticist or a neuropediatric. All clinical data will be&#xD;
      collected.&#xD;
&#xD;
      Strategy of the molecular study :&#xD;
&#xD;
        1. for all multiplex and consanguineous families a linkage analysis (loci ATCAY and ABC7&#xD;
           and others AC known genes) will be performed.&#xD;
&#xD;
        2. For all sporadic patients as well as linked multiplex and consanguineous families :&#xD;
           sequencing of all coding exons of the gene ATCAY and others AC known genes.&#xD;
&#xD;
        3. For all sporadic male patients and linked families : sequencing of all coding exons of&#xD;
           the gene ABC7.&#xD;
&#xD;
        4. For all patients with suggestive features : sequencing of all coding exons of the gene&#xD;
           GPR56, VLDLR, NHE6 or other candidate gene.&#xD;
&#xD;
        5. In consanguineous families : linkage analysis using SNP-array and analysis of candidate&#xD;
           genes present in the regions of extended homozygosity&#xD;
&#xD;
        6. linkage analysis in dominant families and analysis of candidate genes in the linked&#xD;
           regions.&#xD;
&#xD;
        7. If a new AC locus is identified (using linkage or CGH array), this gene will be&#xD;
           sequenced in all patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of the patients with a mutation in one of the analysed genes.</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with severe/moderate/mild/absent intellectual deficiency</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with/without epilepsy/spasticity/extraneurological features and nature and frequency of MRI anomalies</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">165</enrollment>
  <condition>Congenital Cerebellar Ataxias</condition>
  <condition>Early-onset Cerebellar Ataxias</condition>
  <arm_group>
    <arm_group_label>patients ataxic</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>Blood sample will be analysed in order to check presence or not of mutation in ABC7, SLC9A6, GPR56, ATCAY.</description>
    <arm_group_label>patients ataxic</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All types&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient, child or adult, affected with a congenital or early-onset ataxia defined by:&#xD;
&#xD;
          -  Neurological symptoms observed before age of 2 years.&#xD;
&#xD;
          -  Non progressive cerebellar ataxia observed at the time of examination. Karyotype done&#xD;
             or in progress&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metabolic disease&#xD;
&#xD;
          -  Specific MRI malformations suggesting a peculiar entity : molar tooth (joubert&#xD;
             syndrome), superior vermis dysplasia with cleft (Oligophrenin)&#xD;
&#xD;
          -  Muscle weakness and elevated creatine phosphokinase (CPK)&#xD;
&#xD;
          -  Clearly progressive ataxia.&#xD;
&#xD;
          -  Absence of signature of the informed consent.&#xD;
&#xD;
          -  Absence of affiliation to social security&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lydie Burglen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Trousseau, Service de Génétique</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>December 6, 2011</study_first_submitted>
  <study_first_submitted_qc>December 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2011</study_first_posted>
  <last_update_submitted>June 12, 2015</last_update_submitted>
  <last_update_submitted_qc>June 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congenital cerebellar ataxias</keyword>
  <keyword>Genetics</keyword>
  <keyword>Gene ATCAY</keyword>
  <keyword>Gene ABC7</keyword>
  <keyword>Cerebellar atrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ataxia</mesh_term>
    <mesh_term>Cerebellar Ataxia</mesh_term>
    <mesh_term>Spinocerebellar Degenerations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

